Dow Jumps 350 Points After Gilead Says Remdesivir Coronavirus Treatment Reduces Risk Of Death
-
By Sergei Klebnikov, Forbes Staff in Banking & Insurance, Breaking, breaking-news, ETFs & Mutual Funds, Forbes, healthcare, Hedge Funds & Private Equity, Investing, Markets
-
July 10, 2020
The market finished higher as investors cheered positive coronavirus vaccine news.
Read the full post on Forbes - Healthcare
Sergei Klebnikov, Forbes Staff